Capital Research Global Investors Purchases 99,262 Shares of Addus HomeCare Corporation $ADUS

Capital Research Global Investors grew its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 9.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,201,560 shares of the company’s stock after acquiring an additional 99,262 shares during the period. Capital Research Global Investors owned 6.50% of Addus HomeCare worth $141,772,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in ADUS. AlphaQuest LLC acquired a new position in shares of Addus HomeCare in the 3rd quarter valued at about $37,000. State of Wyoming acquired a new stake in Addus HomeCare during the second quarter worth approximately $47,000. Raymond James Financial Inc. bought a new stake in Addus HomeCare in the second quarter worth approximately $61,000. Blue Trust Inc. increased its holdings in Addus HomeCare by 42.9% in the third quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $63,000 after purchasing an additional 161 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its stake in Addus HomeCare by 560.0% in the second quarter. EverSource Wealth Advisors LLC now owns 561 shares of the company’s stock valued at $65,000 after buying an additional 476 shares during the period. 95.35% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO R Dirk Allison sold 4,988 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total transaction of $533,616.24. Following the transaction, the chief executive officer owned 185,514 shares of the company’s stock, valued at $19,846,287.72. The trade was a 2.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Brian Poff sold 2,041 shares of the company’s stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total value of $218,346.18. Following the sale, the executive vice president owned 64,512 shares of the company’s stock, valued at $6,901,493.76. This trade represents a 3.07% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 16,760 shares of company stock valued at $1,786,247. 4.50% of the stock is currently owned by company insiders.

Addus HomeCare Trading Up 0.9%

NASDAQ:ADUS opened at $103.05 on Thursday. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.80 and a quick ratio of 1.80. Addus HomeCare Corporation has a one year low of $88.96 and a one year high of $124.43. The company has a market cap of $1.91 billion, a PE ratio of 19.78, a PEG ratio of 1.42 and a beta of 0.92. The firm has a 50-day moving average of $108.20 and a 200-day moving average of $112.31.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th. Wall Street Zen upgraded shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Monday, February 23rd. Royal Bank Of Canada reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Wednesday, February 25th. BMO Capital Markets started coverage on shares of Addus HomeCare in a report on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price target for the company. Finally, Stephens decreased their price target on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $134.33.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.